SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-13-163994
Filing Date
2013-04-22
Accepted
2013-04-22 08:26:41
Documents
4
Group Members
ODYSSEUS ACQUISITION CORP.VALEANT PHARMACEUTICALS INTERNATIONAL

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A #4 d526060dsctota.htm SC TO-T/A 35897
2 EX-99.(A)(5)(E) d526060dex99a5e.htm EX-99.(A)(5)(E) 10231
3 GRAPHIC g526060g05y36.jpg GRAPHIC 13785
4 GRAPHIC g526060g73g19.jpg GRAPHIC 5456
  Complete submission text file 0001193125-13-163994.txt   74838
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filed by) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806
Business Address 3760 KILROY AIRPORT WAY #500 LONG BEACH CA 90806 562-628-1007
Obagi Medical Products, Inc. (Subject) CIK: 0001375247 (see all company filings)

IRS No.: 954658730 | State of Incorp.: DE | Fiscal Year End: 0710
Type: SC TO-T/A | Act: 34 | File No.: 005-82589 | Film No.: 13772742
SIC: 2834 Pharmaceutical Preparations